Original articleHalf-Fluence Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
Section snippets
Methods
Retrospective review of medical records of 56 patients who had received PDT at the University Eye Clinics of Genova and Torino, Italy, in the last 2 years was conducted. The Institutional Review Board of the University of Genova and Torino approved the study protocol and the collection of data related to all the patients affected by CSC and treated by PDT. The data collection complies with Italian law. The study was conducted in accordance with the provisions stated in the Declaration of
Results
Thirty-one eyes (28 patients) received half-fluence PDT and 29 eyes (28 patients) received half-dose PDT. The baseline demographic data of both groups are shown in Table 1. There were no significant differences between the 2 groups. At baseline, the mean (SD) logMAR BCVA was 0.187 (± 0.187) in the half-fluence group and 0.126 (± 0.091) in the half-dose group. At the last follow-up visit, mean (SD) logMAR BCVA was 0.083 (± 0.164) in the half-fluence group and 0.068 (± 0.091) in the half-dose
Discussion
In this retrospective comparative case series study, we evaluated the efficacy and safety of half-fluence PDT with respect to half-dose PDT in the treatment of chronic CSC. We previously observed that posterior cystoid retinal degeneration is a negative prognostic factor to half-dose PDT outcome; therefore, we excluded eyes with that retinal complication from our study.14
Visual loss in CSC is basically attributable to the chronic persistence of the serous detachment of the neuroepithelium in
Massimo Nicolo', MD, PhD is Assistant Professor and clinical ophthalmologist at University Eye Clinic, Genova, Italy. He completed his Ophthalmology residency and obtained his PhD at University of Genova on 2000. He completed a research fellowship in retinal diseases at New England Eye Center, Tufts University of Boston, US. Dr Nicolo's clinical and research interests include retina, vitreous disease and imaging techniques. He has authored several publications in peer-reviewed journals.
References (21)
- et al.
Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy
Ophthalmology
(1984) - et al.
The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy
Am J Ophthalmol
(2005) - et al.
Retinal atrophy in idiopathic central serous chorioretinopathy
Am J Ophthalmol
(2002) Pathogenesis of disciform detachment of the neuro-epithelium. II. Idiopathic central serous chorioretinopathy
Am J Ophthalmol
(1967)- et al.
Posterior cystoid retinal degeneration in central serous chorioretinopathy
Retina
(2008) Type-A behaviour and central serous chorioretinopathy
Retina
(1987)- et al.
Optical coherence tomography in unilateral resolved central serous chorioretinopathy
Retina
(2005) - et al.
Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study
Retina
(2003) - et al.
Photodynamic therapy for chronic central serous chorioretinopathy
Retina
(2003) Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy
Retina
(2006)
Cited by (0)
Massimo Nicolo', MD, PhD is Assistant Professor and clinical ophthalmologist at University Eye Clinic, Genova, Italy. He completed his Ophthalmology residency and obtained his PhD at University of Genova on 2000. He completed a research fellowship in retinal diseases at New England Eye Center, Tufts University of Boston, US. Dr Nicolo's clinical and research interests include retina, vitreous disease and imaging techniques. He has authored several publications in peer-reviewed journals.
Chiara M. Eandi, MD, PhD, is an Assistant Professor in the Eye Clinic of the Department of Surgical Science, at the University of Torino, Italy. She received her medical degree from the University of Torino in 1998. She completed her ophthalmology residency and obtained her PhD at the University of Torino, Italy. She completed a research fellowship in retinal diseases at the LuEsther T. Mertz Retina Research Center of Manhattan Eye, Ear and Throat Hospital, New York, US. Dr Eandi's clinical and research interests include retina and vitreous diseases and imaging techniques. She has authored several publications in peer-reviewed journals.